The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-s schedule in rats

Psychopharmacology

Volumn 148, Issue 4, 2000, Pages 438-442

  Cousins, Michael S ^a   Seiden, Lewis S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

5 HT 1A receptor; Behavior; Depression; Serotonin re uptake inhibitor

Indexed keywords

ANTIDEPRESSANT AGENT; DRUG VEHICLE; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG SELECTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

EID: 0034067517     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050074     Document Type: Article

References (40)

1. Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51:248-251
2. Bakish D, Hooper CL, Thornton MD, Wiens A, Miller CA, Thibaudeau CA (1997) Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy. Int Clin Psychopharmacol 12:91-97
3. Balcells-Olivero M, Cousins MS, Seiden LS (1998) Holtzman and Harlan Sprague-Dawley rats: differences in 72-sec performance and 8-hydroxy-di-propylamino-tetralin-induced hypothermia. J Pharmacol Exp Ther 286:742-752
4. Berman RM, Anand A, Cappiello A, Miller HL, Hu XS, Oren DA, Charney DS (1999) The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Biol Psychiatry 45:1170-1177
5. Blier P, de MC, Chaput Y (1990) A role for the serotonin system in the mechanism of action of antidepressant treatments: pre-clinical evidence. J Clin Psychiatry 51:14-20
6. Blier P, Bergeron R, de Montigny C (1997) Selective activation of postsynaptic 5-HT-1A receptors induces rapid antidepressant response. Neuropsychopharmacology 16:333-338
7. Cousins MS, Salamone JD (1996) Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioral investigation. Neuroscience 70:849-859
8. Cousins MS, Vosmer G, Overstreet DH, Seiden LS (1999) Rats selectively-bred for responsiveness to 5-HT-1A receptor stimulation: differences in DRL 72-s performance and response to serotonergic drugs. J Pharmacol Exp Ther (in press)
9. Da-Rocha MA, Jr, Puech AJ, Thiebot MH (1997) Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice. J Psychopharmacol 11:211-218
10. Dawson LA, Nguyen HQ (1998) Effects of 5-HT-1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex. Eur J Pharmacol 345: 41-46
11. De Vry J (1995) 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121:1-26
12. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121:66-72
13. Detke MJ, Reneric JP, Lucki I (1996) Pindolol boosts or blocks fluoxetine in the rat forced swimming test (FST) depending on the fluoxetine dose. Soc Neurosci Abstr 22:181
14. Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT (1996) Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 73:337-353
15. Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A (1995) A pharmacological profile of the selective silent 5-HT-1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81-88
16. Fowler SC, Liou JR (1994) Microcatalepsy and disruption of forelimb usage during operant behavior: differences between dopamine D1 (SCH-23390) and D2 (raclopride) antagonists. Psychopharmacology 115:24-30
17. Jolly DC, Richards JB, Seiden LS (1999) Serotonergic mediation of DRL 72-s behavior: receptor subtype involvement in a behavioral screen for antidepressant drugs. Biol Psychiatry 45: 1151-1162
18. Keppel G (1991) Design and analysis: a researcher's handbook, 3rd edn. Prentice-Hall, Upper Saddle River, NJ
19. Maes M, Vandoolaeghe E, Desnyder R (1996) Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression. J Affect Disord 41:201-210
20. Marek GJ, Seiden LS (1988) Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule. J Pharmacol Exp Ther 244:650-658
21. Marek GJ, Li AA, Seiden LS (1989) Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior. J Pharmacol Exp Ther 250:60-71
22. Marek GJ, McDougle CJ, Price LH, Seiden LS (1992) A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology 109:2-11
23. Martin LP, Jackson DM, Wallsten C, Waszczak BL (1999) Electrophysiological comparison of 5-hydroxytryptamine 1A receptor antagonists on dorsal raphe cell firing. J Pharmacol Exp Ther 288:820-826
24. Martin P, Beninger RJ, Hamon M, Puech AJ (1990) Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism. Behav Brain Res 38:135-144
25. McAskill R, Mir S, Taylor D (1998) Pindolol augmentation of antidepressant therapy. Br J Psychiatry 173:203-208
26. Millan MJ, Brocco M, Veiga S, Cistarelli L, Melon C, Gobert A (1998) WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex. Eur J Pharmacol 341:165-167
27. Moser PC, Sanger DJ (1999) 5-HT-1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats. Eur J Pharmacol 372:127-134
28. Perez V, Gilaberte I, Faries D, Alvarez E, Artigas F (1997) Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 349:1594-1597
29. Perez V, Soler J, Puigdemont D, Alvarez E, Artigas F (1999) A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. Arch Gen Psychiatry 56:375-379
30. Porsolt RD, Le PM, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730-732
31. Puzantian T, Kawase K (1999) Does the addition of pindolol accelerate or enhance the response to selective serotonin reuptake inhibitor antidepressants? Pharmacotherapy 19:205-212
32. Rasanen P, Hakko H, Tiihonen J (1999) Mitchell B. Balter Award-1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients. J Clin Psychopharmacol 19:297-302
33. Remy SM, Schreiber R, Dalmus M, De VJ (1996) Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology 125:89-91
34. Richards JB, Sabol KE, Seiden LS (1993) DRL interresponse-time distributions: quantification by peak deviation analysis. J Exp Anal Behav 60:361-385
35. Richards JB, Sabol KE, Hand TH, Jolly DC, Marek GJ, Seiden LS (1994) Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam. Psychopharmacology 114:39-46
36. Seiden LS, Dahms JL, Shaughnessy RA (1985) Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule. Psychopharmacology 86:55-60
37. Sokolowski JD, Seiden LS (1999) The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential reinforcement of low rate 72-second (DRL 72-s) operant schedule in the rat. Psychopharmacology (in press)
38. Tome MB, Isaac MT, Harte R, Holland C (1997) Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int Clin Psychopharmacol 12:81-89
39. Wieland S, Lucki I (1990) Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacology 101:497-504
40. Zanardi R, Artigas F, Franchini L, Sforzini L, Gasperini M, Smeraldi E, Perez J (1997) How long should pindolol be associated with paroxetine to improve the antidepressant response? J Clin Psychopharmacol 17:446-450